JPWO2020014143A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020014143A5
JPWO2020014143A5 JP2021523556A JP2021523556A JPWO2020014143A5 JP WO2020014143 A5 JPWO2020014143 A5 JP WO2020014143A5 JP 2021523556 A JP2021523556 A JP 2021523556A JP 2021523556 A JP2021523556 A JP 2021523556A JP WO2020014143 A5 JPWO2020014143 A5 JP WO2020014143A5
Authority
JP
Japan
Prior art keywords
population
heavy chain
light chain
antibody
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021523556A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531822A (ja
JP7332691B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/040843 external-priority patent/WO2020014143A1/fr
Publication of JP2021531822A publication Critical patent/JP2021531822A/ja
Publication of JPWO2020014143A5 publication Critical patent/JPWO2020014143A5/ja
Priority to JP2023129892A priority Critical patent/JP2023145778A/ja
Application granted granted Critical
Publication of JP7332691B2 publication Critical patent/JP7332691B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021523556A 2018-07-08 2019-07-08 抗体の開発可能性が最大化された抗体ライブラリー Active JP7332691B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023129892A JP2023145778A (ja) 2018-07-08 2023-08-09 抗体の開発可能性が最大化された抗体ライブラリー

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862695065P 2018-07-08 2018-07-08
US62/695,065 2018-07-08
US201962822671P 2019-03-22 2019-03-22
US62/822,671 2019-03-22
PCT/US2019/040843 WO2020014143A1 (fr) 2018-07-08 2019-07-08 Banques d'anticorps ayant des caractéristiques maximisées d'aptitude au développement d'anticorps

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023129892A Division JP2023145778A (ja) 2018-07-08 2023-08-09 抗体の開発可能性が最大化された抗体ライブラリー

Publications (3)

Publication Number Publication Date
JP2021531822A JP2021531822A (ja) 2021-11-25
JPWO2020014143A5 true JPWO2020014143A5 (fr) 2022-11-04
JP7332691B2 JP7332691B2 (ja) 2023-08-23

Family

ID=69102540

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021523556A Active JP7332691B2 (ja) 2018-07-08 2019-07-08 抗体の開発可能性が最大化された抗体ライブラリー
JP2023129892A Pending JP2023145778A (ja) 2018-07-08 2023-08-09 抗体の開発可能性が最大化された抗体ライブラリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023129892A Pending JP2023145778A (ja) 2018-07-08 2023-08-09 抗体の開発可能性が最大化された抗体ライブラリー

Country Status (5)

Country Link
US (5) US10954508B2 (fr)
EP (1) EP3833685A4 (fr)
JP (2) JP7332691B2 (fr)
CA (1) CA3106115A1 (fr)
WO (1) WO2020014143A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3169710A1 (fr) * 2014-07-14 2017-05-24 Amgen Inc. Formulations d'anticorps cristallins
CN118103065A (zh) * 2021-07-07 2024-05-28 儒勒斯贝斯特医药有限公司 使用天然无不利因素cdr的抗体亲和力成熟
US20240093179A1 (en) * 2022-02-17 2024-03-21 Specifica, Inc. Single domain antibody libraries with maximized antibody developability characteristics
WO2023232857A1 (fr) * 2022-06-03 2023-12-07 Ichnos Sciences SA Bibliothèques d'anticorps à chaîne légère commune
WO2024083925A2 (fr) * 2022-10-18 2024-04-25 Tubulis Gmbh Nouveaux anticorps anti-napi2b et conjugués anticorps-médicament basés sur ceux-ci, procédés thérapeutiques et utilisations de ceux-ci
CN118496354A (zh) * 2023-02-15 2024-08-16 三优生物医药(上海)有限公司 包含共同轻链的抗体库、其制备方法及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ312332A (en) 1995-06-07 2000-01-28 Life Technologies Inc Recombinational cloning using engineered recombination sites
EP1054018B1 (fr) 1999-05-18 2009-01-28 Dyax Corp. Banques de fragments Fab et leurs procédes d'utilisation
GB0008419D0 (en) 2000-04-05 2000-05-24 Bioinvent Int Ab A method for invitro molecular evolution of antibody function
US8288322B2 (en) 2000-04-17 2012-10-16 Dyax Corp. Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
US20060160178A1 (en) 2003-11-17 2006-07-20 Jonathan Rothberg Methods of generating antibody diversity in vitro
CA2964398C (fr) 2007-09-14 2023-03-07 Adimab, Llc Bibliotheques d'anticorps synthetiques rationnelles et leurs utilisations
EP2356270B1 (fr) 2008-11-07 2016-08-24 Fabrus Llc Bibliothèques combinatoires d'anticorps et leurs utilisations
WO2016114567A1 (fr) * 2015-01-13 2016-07-21 이화여자대학교 산학협력단 Procédé de préparation d'une nouvelle bibliothèque d'anticorps et bibliothèque ainsi préparée
WO2019126227A1 (fr) * 2017-12-18 2019-06-27 Distributed Bio, Inc. Banque d'anticorps humains radicalement divers

Similar Documents

Publication Publication Date Title
JP2023145778A5 (fr)
Carmena et al. Transposable elements map in a conserved pattern of distribution extending from beta-heterochromatin to centromeres in Drosophila melanogaster
EP1032660B1 (fr) Procede pour identifier des domaines de sites de fixation qui preservent leur capacite de fixation sur un epitope
McConnell et al. Tendamistat as a scaffold for conformationally constrained phage peptide libraries
DE69621940T2 (de) Protein-/(poly)peptidbibliotheken
ES2609102T3 (es) Mutagénesis por revisión
CN103282560B (zh) 抗体文库
JP7332691B2 (ja) 抗体の開発可能性が最大化された抗体ライブラリー
Liu et al. Fine mapping of the antigen–antibody interaction of scFv215, a recombinant antibody inhibiting RNA polymerase II from Drosophila melanogaster
JP2018520639A5 (fr)
JPH08294393A (ja) オリゴヌクレオチド組成物
Morino et al. Antibody fusions with fluorescent proteins: a versatile reagent for profiling protein expression
RU2014133653A (ru) Гуманизированные грызуны, которые экспрессируют тяжелые цепи, содержащие домены vl
IE910336A1 (en) Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")
JP2012504401A5 (fr)
JPWO2020014143A5 (fr)
CN113603775B (zh) 抗人白介素-33单克隆抗体及其应用
Ota et al. Evolution of immunoglobulin VH pseudogenes in chickens.
RU99101121A (ru) Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение
US20230071129A1 (en) Polyclonal mixtures of antibodies, and methods of making and using them
Akashi et al. Antigenic diversity of Akabane virus detected by monoclonal antibodies
Lieberman et al. Close linkage in genes controlling γA and γG heavy chain structure in BALB/c mice
Esteban et al. Generation and characterisation of functional recombinant antibody fragments against RNA replicase NIb from plum pox virus
Early et al. Immunoglobulin gene rearrangements in normal mouse B cells
AU2016202118B2 (en) Carrier immunoglobulins and uses thereof